Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Aeterna Zentaris to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

GlobeNewswire September 9, 2020

Aeterna Zentaris Announced Presentation of Positive Results from First Pediatric Study of Macimorelin at the 22nd European Congress of Endocrinology

GlobeNewswire September 8, 2020

Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire August 6, 2020

Aeterna Zentaris Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire August 5, 2020

AETERNA ZENTARIS ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

GlobeNewswire August 3, 2020

Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications

GlobeNewswire July 31, 2020

AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY

GlobeNewswire July 30, 2020

Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing

GlobeNewswire July 29, 2020

AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING

GlobeNewswire July 7, 2020

AETERNA ZENTARIS ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERING

GlobeNewswire July 1, 2020

AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY

GlobeNewswire June 25, 2020

Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement

GlobeNewswire June 8, 2020

Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements

GlobeNewswire June 4, 2020

Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders

GlobeNewswire May 15, 2020

Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders

GlobeNewswire May 8, 2020

Ancient Medicine Could Trigger New Treatments In Biotech

Livemoney May 7, 2020

Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results

GlobeNewswire May 6, 2020

The Most Exciting Mental Health Breakthrough Of The Decade?

Livemoney May 4, 2020

Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing

GlobeNewswire April 15, 2020

Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit

GlobeNewswire April 15, 2020